| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/14/2004 | US6790631 For diagnosis and therapy of prostate cancer; qualitative analysis |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790617 Megsin promoter |
| 09/14/2004 | US6790615 Methods and compositions for regulating cell cycle progression |
| 09/14/2004 | US6790614 Identifying genetically modified mammalian cells using a mutated protein-tyrosine kinase receptor (ptkr) |
| 09/14/2004 | US6790612 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 09/14/2004 | US6790610 Alzheimer's disease, secretase, APP substrates therefor, and uses therefor |
| 09/14/2004 | US6790606 Extracellular matrix signaling molecules |
| 09/14/2004 | US6790449 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins |
| 09/14/2004 | US6790448 Infection therapy |
| 09/14/2004 | US6790447 Peptides for treatment of autoimmune diseases |
| 09/14/2004 | US6790446 Campylobacter vaccine |
| 09/14/2004 | US6790444 Chimeric antibody comprising human immunoglobin constant region and murine variable region |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | US6790442 Gene expression by immunocompetent cells; antitumor agents, viricides, bactericides, and autoimmuned disease treatment; side effect reduction |
| 09/14/2004 | US6790439 Thrombopoietin compositions |
| 09/14/2004 | CA2219629C Transgenic animal models for type ii diabetes mellitus |
| 09/14/2004 | CA2130115C Prevention of retinal injury and degeneration by specific factors |
| 09/14/2004 | CA2113829C Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 09/14/2004 | CA2073113C Conjugates |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004076684A2 Compositions and methods for the detection of mammalian muscle troponin i |
| 09/10/2004 | WO2004076675A2 Glutamate transport modulatory compounds and methods |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076665A2 Vaccines derived from epithelial cell mucin muc-1 |
| 09/10/2004 | WO2004076662A1 Scaffold associated regions sequences and the use thereof |
| 09/10/2004 | WO2004076660A1 Virus-adsorbing protein and use thereof |
| 09/10/2004 | WO2004076645A2 Compositions and methods for cytomegalovirus treatment |
| 09/10/2004 | WO2004076638A2 Polynucleotides and polypeptides in plants |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076635A2 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | WO2004076634A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
| 09/10/2004 | WO2004076633A2 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076631A2 Biologically active native biomatrix composition |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076619A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 09/10/2004 | WO2004076614A2 Human nucleic acid sequences obtained from prostatic carcinomas |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076485A1 Antibody purification by protein a and ion exchange chromatography |
| 09/10/2004 | WO2004076484A1 Peptide inhibitors of thrombin as potent anticoagulants |
| 09/10/2004 | WO2004076483A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004076481A2 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus |
| 09/10/2004 | WO2004076480A1 Tumour marker and its use |
| 09/10/2004 | WO2004076479A2 Soluble ctla4 polypeptides and methods for making the same |
| 09/10/2004 | WO2004076474A2 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
| 09/10/2004 | WO2004075912A1 Use of pgrp, lrrp and ctl proteins to trigger an anti-plasmodium immune response in anopheles species |
| 09/10/2004 | WO2004075911A1 Chemokine binding protein and use thereof |
| 09/10/2004 | WO2004075910A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 09/10/2004 | WO2004075861A2 Recombinant adeno-associated virus production |
| 09/10/2004 | WO2004075850A2 Polyvalent immunogen |
| 09/10/2004 | WO2004075843A2 Glycosolated enkephalin agents |
| 09/10/2004 | WO2004075842A2 Mrp3 genes and uses thereof |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075836A2 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075818A2 Stress specific molecular response in neurons |
| 09/10/2004 | WO2004075725A2 Bcrm-1 genes and uses thereof |
| 09/10/2004 | WO2004075723A2 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | WO2004075635A2 Crystal structure of the ternary compelex of 14-3-3, fusicoccin and plasma membrane atpase and methods for designing new herbicides |
| 09/10/2004 | WO2004065626A3 A method of sepsis prognosis |
| 09/10/2004 | WO2004062583A3 Vaccine and method for preventing biofilm formation |
| 09/10/2004 | WO2004058944A3 Product quality enhancement in mammalian cell culture processes for protein production |
| 09/10/2004 | WO2004058803A3 Peptides that bind of the vegfr-2 |
| 09/10/2004 | WO2004056173A3 Generation of plants with altered oil content |
| 09/10/2004 | WO2004053092A3 Human pellino polypeptides |
| 09/10/2004 | WO2004052281A3 Oral lactoferrin in the treatment of sepsis |
| 09/10/2004 | WO2004047854A3 Methods for the treatment of alzheimers disease and compositions therefore |
| 09/10/2004 | WO2004045548A3 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 09/10/2004 | WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 09/10/2004 | WO2004044147A3 Modified dendritic cells |
| 09/10/2004 | WO2004042075A3 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use |
| 09/10/2004 | WO2004039841A3 Trimeric binding proteins for trimeric cytokines |
| 09/10/2004 | WO2004037278A3 Delocalization molecules and use thereof |
| 09/10/2004 | WO2004035737A3 Heterocyclic selective androgen receptor modulators and methods of use thereof |
| 09/10/2004 | WO2004035624A3 Glucagon - like peptide - 2 variants |
| 09/10/2004 | WO2004033695A3 A promoter from streptomyces coelicolor |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2004030622A3 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 09/10/2004 | WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 09/10/2004 | WO2004023867A3 Transgenic cancer models in fish |
| 09/10/2004 | WO2004023093A3 Target and method for inhibition of bacterial rna polymerase |
| 09/10/2004 | WO2004022723A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/10/2004 | WO2004018995A3 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2004009622A3 Protein complexes of cellular networks underlying the development of cancer and other diseases |
| 09/10/2004 | WO2004009027A3 Method and composition for treating and preventing herpesvirus infection |
| 09/10/2004 | WO2003106970A3 P27 prevents cellular migration |
| 09/10/2004 | WO2003100021A3 Methods and dna constructs for high yield production of polypeptides |
| 09/10/2004 | WO2003094844A3 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
| 09/10/2004 | WO2003093296A3 Kinase anchor protein muteins, peptides thereof, and related methods |
| 09/10/2004 | WO2003082079A3 Diagnostics for the detection of acidovorax avenae subsp. citrulli, causal agent of bacterial fruit blotch in melons |
| 09/10/2004 | WO2003076643A3 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/10/2004 | WO2003076579A3 Cancer-linked gene as target for chemotherapy |